The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19

Introduction: COVID-19 can range from asymptomatic to critical illness and may result in mortality. In our study, we aimed to evaluate the effect of clinical, laboratory, and radiological findings on mortality in patients diagnosed with severe COVID-19. Materials and Methods: We included SARS-CoV-...

Full description

Bibliographic Details
Main Authors: Sudem MAHMUTOĞLU ÇOLAK, Tuba İLGAR, Süleyman Koç, Kübra Akyüz, Gülsün ÇAKIR ODABAŞ, Özcan Yavaş
Format: Article
Language:English
Published: Bilimsel Tip Yayinevi 2023-09-01
Series:Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Subjects:
Online Access:http://www.floradergisi.org/managete/fu_folder/2023-03/2023-28-03-371-382.pdf
_version_ 1797676954502037504
author Sudem MAHMUTOĞLU ÇOLAK
Tuba İLGAR
Süleyman Koç
Kübra Akyüz
Gülsün ÇAKIR ODABAŞ
Özcan Yavaş
author_facet Sudem MAHMUTOĞLU ÇOLAK
Tuba İLGAR
Süleyman Koç
Kübra Akyüz
Gülsün ÇAKIR ODABAŞ
Özcan Yavaş
author_sort Sudem MAHMUTOĞLU ÇOLAK
collection DOAJ
description Introduction: COVID-19 can range from asymptomatic to critical illness and may result in mortality. In our study, we aimed to evaluate the effect of clinical, laboratory, and radiological findings on mortality in patients diagnosed with severe COVID-19. Materials and Methods: We included SARS-CoV-2 polymerase chain reaction (PCR) positive patients followed up in infectious diseases pandemic and chest diseases pandemic departments at Rize State Hospital in 01.01.2020-31.03.2021. Epidemiological data, chronic diseases, admission symptoms, laboratory findings, and radiological findings of the patients were recorded retrospectively from the patient files. Patients were grouped as survivors and non-survivors. We defined severe disease as patients with pneumonia on radiological imaging, oxygen saturation < 0.05. Results: 135 patients, 110 of whom were survivors and 25 non-survivors, were included in the study. The mean age was 65.5 ± 15.45 years and 61.5% (n= 83) of patients were male. The mean age of the non-survivors was higher compared to survivors (p= 0.007). The mortality rates in patients with coronary artery disease (CAD) and chronic kidney disease (CKD) were statistically higher in non-survivors (p= 0.032, p= 0.032). The rate of tachypnea was found to be statistically higher in the non-survivors (p= 0.001). During the follow-up period, chest X-rays were taken every other day for assessment. The rate of progression was found to be statistically significantly higher in non-survivors (p= 0.004). According to the results of the multivariate logistic regression analysis, the presence of CAD, tachypnea at hospital admission, and progression in chest X-ray were considered independent risk factors for mortality. Conclusion: In this study, the factors that may worsen the disease in the severe COVID-19 disease course were estimated and the presence of CAD, tachypnea, and progression in chest X-ray was found to be independent risk factors for mortality. In addition to chronic diseases and symptoms at presentation, the detection of progression in chest X-ray in the clinical follow-up of patients is a risk factor for mortality, which shows us that radiological follow-up should be kept in mind during the course of the disease.
first_indexed 2024-03-11T22:37:57Z
format Article
id doaj.art-6104aaf73eef446caa4b6106a54edba0
institution Directory Open Access Journal
issn 1300-932X
language English
last_indexed 2024-03-11T22:37:57Z
publishDate 2023-09-01
publisher Bilimsel Tip Yayinevi
record_format Article
series Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
spelling doaj.art-6104aaf73eef446caa4b6106a54edba02023-09-22T11:19:27ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X2023-09-0128337138210.5578/flora.20239707The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19Sudem MAHMUTOĞLU ÇOLAK0https://orcid.org/0000-0001-7214-2305Tuba İLGAR1https://orcid.org/0000-0003-2476-8295Süleyman Koç2https://orcid.org/0000-0003-0225-2124Kübra Akyüz3https://orcid.org/0000-0002-4952-1689Gülsün ÇAKIR ODABAŞ4https://orcid.org/0000-0002-9815-8150Özcan Yavaş5https://orcid.org/0000-0001-8641-7031Clinic of Infectious Diseases and Clinical Microbiology, Recep Tayyip Erdoğan University Training and Research Hospital, Rize, TürkiyeClinic of Infectious Diseases and Clinical Microbiology, Recep Tayyip Erdoğan University Training and Research Hospital, Rize, TürkiyeClinic of Infectious Diseases and Clinical Microbiology, Rize State Hospital, Rize, TürkiyeClinic of Chest Diseases, Rize State Hospital, Rize, TürkiyeClinic of Chest Diseases, Rize State Hospital, Rize, TürkiyeDepartment of Emergency Medicine, Recep Tayyip Erdoğan University Training and Research Hospital, Rize, TürkiyeIntroduction: COVID-19 can range from asymptomatic to critical illness and may result in mortality. In our study, we aimed to evaluate the effect of clinical, laboratory, and radiological findings on mortality in patients diagnosed with severe COVID-19. Materials and Methods: We included SARS-CoV-2 polymerase chain reaction (PCR) positive patients followed up in infectious diseases pandemic and chest diseases pandemic departments at Rize State Hospital in 01.01.2020-31.03.2021. Epidemiological data, chronic diseases, admission symptoms, laboratory findings, and radiological findings of the patients were recorded retrospectively from the patient files. Patients were grouped as survivors and non-survivors. We defined severe disease as patients with pneumonia on radiological imaging, oxygen saturation < 0.05. Results: 135 patients, 110 of whom were survivors and 25 non-survivors, were included in the study. The mean age was 65.5 ± 15.45 years and 61.5% (n= 83) of patients were male. The mean age of the non-survivors was higher compared to survivors (p= 0.007). The mortality rates in patients with coronary artery disease (CAD) and chronic kidney disease (CKD) were statistically higher in non-survivors (p= 0.032, p= 0.032). The rate of tachypnea was found to be statistically higher in the non-survivors (p= 0.001). During the follow-up period, chest X-rays were taken every other day for assessment. The rate of progression was found to be statistically significantly higher in non-survivors (p= 0.004). According to the results of the multivariate logistic regression analysis, the presence of CAD, tachypnea at hospital admission, and progression in chest X-ray were considered independent risk factors for mortality. Conclusion: In this study, the factors that may worsen the disease in the severe COVID-19 disease course were estimated and the presence of CAD, tachypnea, and progression in chest X-ray was found to be independent risk factors for mortality. In addition to chronic diseases and symptoms at presentation, the detection of progression in chest X-ray in the clinical follow-up of patients is a risk factor for mortality, which shows us that radiological follow-up should be kept in mind during the course of the disease. http://www.floradergisi.org/managete/fu_folder/2023-03/2023-28-03-371-382.pdfsevere covid-19risk factorsmortalityprogression
spellingShingle Sudem MAHMUTOĞLU ÇOLAK
Tuba İLGAR
Süleyman Koç
Kübra Akyüz
Gülsün ÇAKIR ODABAŞ
Özcan Yavaş
The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
severe covid-19
risk factors
mortality
progression
title The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19
title_full The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19
title_fullStr The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19
title_full_unstemmed The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19
title_short The Effect of Clinical, Laboratory and Radiological Findings on Mortality in Patients with Severe COVID-19
title_sort effect of clinical laboratory and radiological findings on mortality in patients with severe covid 19
topic severe covid-19
risk factors
mortality
progression
url http://www.floradergisi.org/managete/fu_folder/2023-03/2023-28-03-371-382.pdf
work_keys_str_mv AT sudemmahmutoglucolak theeffectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT tubailgar theeffectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT suleymankoc theeffectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT kubraakyuz theeffectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT gulsuncakirodabas theeffectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT ozcanyavas theeffectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT sudemmahmutoglucolak effectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT tubailgar effectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT suleymankoc effectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT kubraakyuz effectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT gulsuncakirodabas effectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19
AT ozcanyavas effectofclinicallaboratoryandradiologicalfindingsonmortalityinpatientswithseverecovid19